Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 77 results.
User Information
Export Records
  1. 1.   Comparison of GD2 binding capture ELISA assays for anti-GD2-antibodies using GD2-coated plates and a GD2-expressing cell-based ELISA
  2. Soman, G.; Yang, X. Y.; Jiang, H. G.; Giardina, S.; Mitra, G.
  3. Journal of Immunological Methods. 2011, Oct; 373(1-2): 181-191.
  1. 2.   Association of Src-Related Kinase Lyn with the Interleukin-2 Receptor and Its Role in Maintaining Constitutive Phosphorylation of JAK/STAT in Human T-Cell Leukemia Virus Type 1-Transformed T Cells
  2. Shuh, M. S. M.; Morse, B. A.; Heidecker, G.; Derse, D.
  3. Journal of Virology. 2011, May; 85(9): 4623-4627.
  1. 3.   Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
  2. Butterfield, L. H.; Palucka, A. K.; Britten, C. M.; Dhodapkar, M. V.; Hakansson, L.; Janetzki, S.; Kawakami, Y.; Kleen, T. O.; Lee, P. P.; Maccalli, C.; Maecker, H. T.; Maino, V. C.; Maio, M.; Malyguine, A.; Masucci, G.; Pawelec, G.; Potter, D. M.; Rivoltini, L.; Salazar, L. G.; Schendel, D. J.; Slingluff, C. L.; Song, W. R.; Stroncek, D. F.; Tahara, H.; Thurin, M.; Trinchieri, G.; van Der Burg, S. H.; Whiteside, T. L.; Wigginton, J. M.; Marincola, F.; Khleif, S.; Fox, B. A.; Disis, M. L.
  3. Clinical Cancer Research. 2011, May; 17(10): 3064-3076.
  1. 4.   Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
  2. Buhtoiarov, I. N.; Sondel, P. M.; Wigginton, J. M.; Buhtoiarova, T. N.; Yanke, E. M.; Mahvi, D. A.; Rakhmilevich, A. L.
  3. Immunology. 2011, Feb; 132(2): 226-239.
  1. 5.   Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
  2. Shusterman, S.; London, W. B.; Gillies, S. D.; Hank, J. A.; Voss, S. D.; Seeger, R. C.; Reynolds, C. P.; Kimball, J.; Albertini, M. R.; Wagner, B.; Gan, J.; Eickhoff, J.; DeSantes, K. B.; Cohn, S. L.; Hecht, T.; Gadbaw, B.; Reisfeld, R. A.; Maris, J. M.; Sondel, P. M.
  3. Journal of Clinical Oncology. 2010, Nov; 28(33): 4969-4975.
  1. 6.   Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial
  2. Bobe, G.; Murphy, G.; Albert, P. S.; Sansbury, L. B.; Lanza, E.; Schatzkin, A.; Colburn, N. H.; Cross, A. J.
  3. British Journal of Cancer. 2010, Oct; 103(9): 1453-1461.
  1. 7.   Sleeping Beauty-Mediated Somatic Mutagenesis Implicates CSF1 in the Formation of High-Grade Astrocytomas
  2. Bender, A. M.; Collier, L. S.; Rodriguez, F. J.; Tieu, C.; Larson, J. D.; Halder, C.; Mahlum, E.; Kollmeyer, T. M.; Akagi, K.; Sarkar, G.; Largaespada, D. A.; Jenkins, R. B.
  3. Cancer Research. 2010, May; 70(9): 3557-3565.
  1. 8.   Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo
  2. Suh, H. C.; Leeanansaksiri, W.; Ji, M.; Klarmann, K. D.; Renn, K.; Gooya, J.; Smith, D.; McNiece, I.; Lugthart, S.; Valk, P. J.; Delwel, R.; Keller, J. R.
  3. Oncogene. 2008, Sep 18; 27(42): 5612-5623.
  1. 9.   Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins
  2. Ji, M.; Li, H. J.; Suh, H. C.; Klarmann, K. D.; Yokota, Y.; Keller, J. R.
  3. Blood. 2008 112(4): 1068-1077.
  1. 10.   Immunotherapy of cancer by IL-12-based cytokine combinations
  2. Weiss, J. M.; Subleski, J. J.; Wigginton, J. M.; Wiltrout, R. H.
  3. Expert Opinion on Biological Therapy. 2007, Nov; 7(11): 1705-1721.
  1. 11.   IFN-gamma-Mediated survival enables human Neutrophils to produce MCP-1/CCL2 in response to activation by TLR Ligands
  2. Yoshimura, T.; Takahashi, M.
  3. Journal of Immunology. 2007, Aug; 179(3): 1942-1949.
  1. 12.   IL-7 induces myelopoiesis and erythropoiesis
  2. Aiello, F. B.; Keller, J. R.; Klarmann, K. D.; Dranoff, G.; Mazzucchelli, R.; Durum, S. K.
  3. Journal of Immunology. 2007, Feb; 178(3): 1553-1563.
  1. 13.   The birth of a cell type
  2. Trinchieri, G.
  3. Journal of Immunology. 2007, Jan; 178(1): 3-4.
  1. 14.   C/EBP alpha determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation
  2. Suh, H. C.; Gooya, J.; Renn, K.; Friedman, A. D.; Johnson, P. F.; Keller, J. R.
  3. Blood. 2006, Jun; 107(11): 4308-4316.
  1. 15.   Impact of vaccine-induced mucosal high-avidity CD8(+)CTLs in delay of AIDS viral dissemination from mucosa
  2. Belyakov, I. M.; Kuznetsov, V. A.; Kelsall, B.; Klinman, D.; Moniuszko, M.; Lemon, M.; Markham, P. D.; Pal, R.; Clements, J. D.; Lewis, M. G.; Strober, W.; Franchini, G. A.; Berzofsky, J. A.
  3. Blood. 2006, Apr; 107(8): 3258-3264.
  1. 16.   Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR
  2. Boyd, K. E.; Xiao, Y. Y.; Fan, K.; Poholek, A.; Copeland, N. G.; Jenkins, N. A.; Perkins, A. S.
  3. Blood. 2006, JAN 15; 107(2): 733-741.
  1. 17.   Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response
  2. Ji, Q. Y.; Gondek, D.; Hurwitz, A. A.
  3. Journal of Immunology. 2005, AUG 1; 175(3): 1456-1463.
  1. 18.   Calcium-dependent activation of interleukin-21 gene expression in T cells
  2. Kim, H. P.; Korn, L. L.; Gamero, A. M.; Leonard, W. J.
  3. Journal of Biological Chemistry. 2005, JUL 1; 280(26): 25291-25297.
  1. 19.   Ex vivo expanded murine bone marrow cells with a multiple cytokine cocktail retain long-term hematopoietic reconstitution potentials
  2. Yang, Q. E.; Fong, S. E.; Li, K. G.; Gonda, M. A.; Tobin, G. J.
  3. Medical Science Monitor. 2005, JUN; 11(6): BR154-BR161.
  1. 20.   IL-3 induces inhibitor of DNA-binding protein-1 in hemopoietic progenitor cells and promotes myeloid cell development
  2. Leeanansaksiri, W.; Wang, H.; Gooya, J. M.; Renn, K.; Abshari, M.; Tsai, S.; Keller, J. R.
  3. Journal of Immunology. 2005, JUN 1; 174(11): 7014-7021.
  1. 21.   A model of the ternary complex of interleukin-10 with its soluble receptors
  2. Pletnev, S.; Magracheva, E.; Wlodawer, A.; Zdanov, A.
  3. Bmc Structural Biology. 2005, Jun; 5
  1. 22.   Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen
  2. Neelapu, S. S.; Baskar, S.; Gause, B. L.; Kobrin, C. B.; Watson, T. M.; Frye, A. R.; Pennington, R.; Harvey, L.; Jaffe, E. S.; Robb, R. J.; Popescu, M. C.; Kwak, L. W.
  3. Clinical Cancer Research. 2004, DEC 15; 10(24): 8309-8317.
  1. 23.   Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and -independent contributions from c-Kit
  2. Lennartsson, J.; Shivakrupa, R.; Linnekin, D.
  3. Journal of Biological Chemistry. 2004, OCT 22; 279(43): 44544-44553.
  1. 24.   C/EBP alpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo
  2. Heath, V.; Suh, H. C.; Holman, M.; Renn, K.; Gooya, J. M.; Parkin, S.; Klarmann, K. D.; Ortiz, M.; Johnson, P.; Keller, J.
  3. Blood. 2004, SEP 15; 104(6): 1639-1647.
  1. 25.   Therapeutic idiotype vaccines in B lymphoproliferative diseases
  2. Coscia, M.; Kwak, L. W.
  3. Expert Opinion on Biological Therapy. 2004 4(6): 959-963.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel